Sanofi (SNY) P/E (2007 - 2026)
Sanofi (SNY) P/E from Jul 2, 2007 to Jul 21, 2026. The TTM Sanofi (SNY) P/E is 12.14. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Sanofi (SNY)
| Year | P/E | Change |
|---|---|---|
| 2026 | 12.14 | -8.55% |
| 2025 | 13.28 | -33.31% |
| 2024 | 19.91 | +54.97% |
| 2023 | 12.85 | -28.22% |
| 2022 | 17.90 | +3.12% |
| 2021 | 17.36 | +99.16% |
| 2020 | 8.72 | -78.53% |
| 2019 | 40.61 | +89.74% |
| 2018 | 21.40 | +95.80% |
| 2017 | 10.93 | -50.04% |
| 2016 | 21.88 | -7.15% |
| 2015 | 23.56 | +11.48% |
| 2014 | 21.13 | -26.19% |
| 2013 | 28.64 | +46.21% |
| 2012 | 19.59 | +31.35% |
| 2011 | 14.91 | +27.03% |
| 2010 | 11.74 | -15.51% |
| 2009 | 13.89 | -20.33% |
| 2008 | 17.44 | -20.69% |
| 2007 | 21.99 | N/A |
Comparison Sanofi (SNY) P/E with competitors
Sanofi (SNY) P/E is 12.14.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| GRFS | Grifols SA | 10.11 | -16.75% |
| PFE | Pfizer Inc | 11.65 | -4.03% |
| NVO | Novo Nordisk | 11.79 | -2.90% |
| GSK | GSK Plc | 12.10 | -0.33% |
| BMY | Bristol-Myers Squibb Company | 13.82 | +13.80% |
| OGN | Organon & Company | 14.33 | +17.98% |
| BIIB | Biogen Inc | 17.41 | +43.33% |
| GILD | Gilead Sciences Inc | 17.75 | +46.12% |
| NVS | Novartis AG | 21.60 | +77.84% |
| JNJ | Johnson & Johnson | 22.09 | +81.89% |
| AMGN | AMGEN Inc | 24.75 | +103.82% |
| MRK | Merck & Co Inc | 26.93 | +121.74% |
| AZN | Astrazeneca plc | 28.44 | +134.22% |
| LLY | Lilly(Eli) & Company | 48.44 | +298.91% |
| ABBV | Abbvie Inc | 139.08 | +1045.29% |